| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 13 | |
| #2 | Australia | 12 | |
| #3 | Canada | 10 | |
| #4 | EPO (European Patent Office) | 9 | |
| #5 | United States | 9 | |
| #6 | WIPO (World Intellectual Property Organization) | 8 | |
| #7 | China | 7 | |
| #8 | Hong Kong | 6 | |
| #9 | Singapore | 6 | |
| #10 | Israel | 5 | |
| #11 | Republic of Korea | 5 | |
| #12 | Mexico | 4 | |
| #13 | New Zealand | 4 | |
| #14 | South Africa | 4 | |
| #15 | EAPO (Eurasian Patent Organization) | 3 | |
| #16 | Serbia | 3 | |
| #17 | Hungary | 2 | |
| #18 | Japan | 2 | |
| #19 | Malaysia | 2 | |
| #20 | Philippines | 2 | |
| #21 | Brazil | 1 | |
| #22 | Chile | 1 | |
| #23 | India | 1 | |
| #24 | Norway | 1 | |
| #25 | Peru | 1 | |
| #26 | Russian Federation | 1 | |
| #27 | Slovenia | 1 | |
| #28 | Ukraine | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Agriculture | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Animal care | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wraith David | 91 |
| #2 | Streeter Heather | 31 |
| #3 | Martin Keith | 19 |
| #4 | Vrolix Kathleen | 9 |
| #5 | Jahraus Andrea | 9 |
| #6 | Jansson Lotta | 9 |
| #7 | Ordonez Laurence | 8 |
| #8 | David Wraith | 8 |
| #9 | Selli Mehmet | 5 |
| #10 | Somers Veerle | 5 |
| Publication | Filing date | Title |
|---|---|---|
| GB201919222D0 | Composition | |
| EP3565585A1 | Therapeutic method using tolerogenic peptides | |
| AU2018206358A1 | S-Arrestin peptides and therapeutic uses thereof | |
| GB201700095D0 | Composition | |
| GB201603582D0 | Peptides | |
| AU2015370415A1 | Composition | |
| GB201520190D0 | Composition | |
| GB201520199D0 | Composition | |
| GB201520196D0 | Composition | |
| AU2014200237A1 | FVIII peptides and their use in tolerising haemophiliacs | |
| NZ708812A | Fviii peptides, compositions and uses of same | |
| GB201316660D0 | Peptides | |
| GB201314052D0 | Peptides | |
| GB201300684D0 | Peptide | |
| GB201300683D0 | Peptide | |
| GB201220328D0 | Peptides | |
| GB201200624D0 | Peptide | |
| GB201200623D0 | Peptide | |
| AU2008237878A1 | Biomarkers for multiple sclerosis |